Loading…
Role of Plasminogen Activator Inhibitor-1 in Promoting Fibrin Deposition in Rabbits Infused with Ancrod or Thrombin
The role of defective, fibrinolysis caused by elevated activity of plasminogen activator inhibitor-1 (PAI-1) in promoting fibrin deposition in vivo has not been well established. The present study compared the efficacy of thrombin or ancrod, a venom-derived enzyme that clots fibrinogen, to induce fi...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Report |
Language: | English |
Subjects: | |
Online Access: | Request full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | |
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | Krishnamurti, Chitra Bolan, Charles Colleton, Curtis A Reilly, Thomas M Alving, Barbara M |
description | The role of defective, fibrinolysis caused by elevated activity of plasminogen activator inhibitor-1 (PAI-1) in promoting fibrin deposition in vivo has not been well established. The present study compared the efficacy of thrombin or ancrod, a venom-derived enzyme that clots fibrinogen, to induce fibrin formation in rabbits with elevated PAI-1 levels. One set of male New Zealand rabbits received intravenous endotoxin to increase endogenous PAI-1 activity followed by a 1 -hour infusion of ancrod or thrombin; another set of normal rabbits received intravenous human recombinant PAI-1 (rPAI-1) during an infusion of ancrod or thrombin. Thirty minutes after the end of the infusion, renal fibrin deposition was assessed by histopathology. Animals receiving endotoxin, rPAI-1 , ancrod, or thrombin alone did not develop renal thrombi.
Pub. in Blood, v82, n12, p3631-3636, 15 Dec 1993. |
format | report |
fullrecord | <record><control><sourceid>dtic_1RU</sourceid><recordid>TN_cdi_dtic_stinet_ADA275301</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ADA275301</sourcerecordid><originalsourceid>FETCH-dtic_stinet_ADA2753013</originalsourceid><addsrcrecordid>eNqFjLEOgkAQRGksjPoHFvsDJCIx1heRaEcIPbmDAzaBXXN76u-7JvZWM5k3M-tEap498ADVbGVB4tETmC7iy0YOcKcJHapLM0CCKvDCEWmEEl3QoPAPFozI9MW1dVoWXQ1P8T28MU5gqAvcg541k84d0jZZDXYWv_vpJtmX1-ZyS_uIXSv672NrCnM8n_JDlv_BHw6-QKI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>report</recordtype></control><display><type>report</type><title>Role of Plasminogen Activator Inhibitor-1 in Promoting Fibrin Deposition in Rabbits Infused with Ancrod or Thrombin</title><source>DTIC Technical Reports</source><creator>Krishnamurti, Chitra ; Bolan, Charles ; Colleton, Curtis A ; Reilly, Thomas M ; Alving, Barbara M</creator><creatorcontrib>Krishnamurti, Chitra ; Bolan, Charles ; Colleton, Curtis A ; Reilly, Thomas M ; Alving, Barbara M ; WALTER REED ARMY INST OF RESEARCH WASHINGTON DC</creatorcontrib><description>The role of defective, fibrinolysis caused by elevated activity of plasminogen activator inhibitor-1 (PAI-1) in promoting fibrin deposition in vivo has not been well established. The present study compared the efficacy of thrombin or ancrod, a venom-derived enzyme that clots fibrinogen, to induce fibrin formation in rabbits with elevated PAI-1 levels. One set of male New Zealand rabbits received intravenous endotoxin to increase endogenous PAI-1 activity followed by a 1 -hour infusion of ancrod or thrombin; another set of normal rabbits received intravenous human recombinant PAI-1 (rPAI-1) during an infusion of ancrod or thrombin. Thirty minutes after the end of the infusion, renal fibrin deposition was assessed by histopathology. Animals receiving endotoxin, rPAI-1 , ancrod, or thrombin alone did not develop renal thrombi.
Pub. in Blood, v82, n12, p3631-3636, 15 Dec 1993.</description><language>eng</language><subject>ANIMALS ; Biochemistry ; BLOOD COAGULATION ; DEPOSITION ; ENDOTOXINS ; ENZYME PRECURSORS ; ENZYMES ; FIBRIN ; FIBRINOGEN ; FIBRINOLYSIS ; HISTOPATHOLOGY ; HUMANS ; IN VIVO ANALYSIS ; INFUSIONS ; INHIBITORS ; MALES ; NEW ZEALAND ; PHYSIOLOGY ; RABBITS ; REPRINTS ; THROMBIN ; VENOMS</subject><creationdate>1993</creationdate><rights>Approved for public release; distribution is unlimited.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,776,881,27543,27544</link.rule.ids><linktorsrc>$$Uhttps://apps.dtic.mil/sti/citations/ADA275301$$EView_record_in_DTIC$$FView_record_in_$$GDTIC$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Krishnamurti, Chitra</creatorcontrib><creatorcontrib>Bolan, Charles</creatorcontrib><creatorcontrib>Colleton, Curtis A</creatorcontrib><creatorcontrib>Reilly, Thomas M</creatorcontrib><creatorcontrib>Alving, Barbara M</creatorcontrib><creatorcontrib>WALTER REED ARMY INST OF RESEARCH WASHINGTON DC</creatorcontrib><title>Role of Plasminogen Activator Inhibitor-1 in Promoting Fibrin Deposition in Rabbits Infused with Ancrod or Thrombin</title><description>The role of defective, fibrinolysis caused by elevated activity of plasminogen activator inhibitor-1 (PAI-1) in promoting fibrin deposition in vivo has not been well established. The present study compared the efficacy of thrombin or ancrod, a venom-derived enzyme that clots fibrinogen, to induce fibrin formation in rabbits with elevated PAI-1 levels. One set of male New Zealand rabbits received intravenous endotoxin to increase endogenous PAI-1 activity followed by a 1 -hour infusion of ancrod or thrombin; another set of normal rabbits received intravenous human recombinant PAI-1 (rPAI-1) during an infusion of ancrod or thrombin. Thirty minutes after the end of the infusion, renal fibrin deposition was assessed by histopathology. Animals receiving endotoxin, rPAI-1 , ancrod, or thrombin alone did not develop renal thrombi.
Pub. in Blood, v82, n12, p3631-3636, 15 Dec 1993.</description><subject>ANIMALS</subject><subject>Biochemistry</subject><subject>BLOOD COAGULATION</subject><subject>DEPOSITION</subject><subject>ENDOTOXINS</subject><subject>ENZYME PRECURSORS</subject><subject>ENZYMES</subject><subject>FIBRIN</subject><subject>FIBRINOGEN</subject><subject>FIBRINOLYSIS</subject><subject>HISTOPATHOLOGY</subject><subject>HUMANS</subject><subject>IN VIVO ANALYSIS</subject><subject>INFUSIONS</subject><subject>INHIBITORS</subject><subject>MALES</subject><subject>NEW ZEALAND</subject><subject>PHYSIOLOGY</subject><subject>RABBITS</subject><subject>REPRINTS</subject><subject>THROMBIN</subject><subject>VENOMS</subject><fulltext>true</fulltext><rsrctype>report</rsrctype><creationdate>1993</creationdate><recordtype>report</recordtype><sourceid>1RU</sourceid><recordid>eNqFjLEOgkAQRGksjPoHFvsDJCIx1heRaEcIPbmDAzaBXXN76u-7JvZWM5k3M-tEap498ADVbGVB4tETmC7iy0YOcKcJHapLM0CCKvDCEWmEEl3QoPAPFozI9MW1dVoWXQ1P8T28MU5gqAvcg541k84d0jZZDXYWv_vpJtmX1-ZyS_uIXSv672NrCnM8n_JDlv_BHw6-QKI</recordid><startdate>19931215</startdate><enddate>19931215</enddate><creator>Krishnamurti, Chitra</creator><creator>Bolan, Charles</creator><creator>Colleton, Curtis A</creator><creator>Reilly, Thomas M</creator><creator>Alving, Barbara M</creator><scope>1RU</scope><scope>BHM</scope></search><sort><creationdate>19931215</creationdate><title>Role of Plasminogen Activator Inhibitor-1 in Promoting Fibrin Deposition in Rabbits Infused with Ancrod or Thrombin</title><author>Krishnamurti, Chitra ; Bolan, Charles ; Colleton, Curtis A ; Reilly, Thomas M ; Alving, Barbara M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-dtic_stinet_ADA2753013</frbrgroupid><rsrctype>reports</rsrctype><prefilter>reports</prefilter><language>eng</language><creationdate>1993</creationdate><topic>ANIMALS</topic><topic>Biochemistry</topic><topic>BLOOD COAGULATION</topic><topic>DEPOSITION</topic><topic>ENDOTOXINS</topic><topic>ENZYME PRECURSORS</topic><topic>ENZYMES</topic><topic>FIBRIN</topic><topic>FIBRINOGEN</topic><topic>FIBRINOLYSIS</topic><topic>HISTOPATHOLOGY</topic><topic>HUMANS</topic><topic>IN VIVO ANALYSIS</topic><topic>INFUSIONS</topic><topic>INHIBITORS</topic><topic>MALES</topic><topic>NEW ZEALAND</topic><topic>PHYSIOLOGY</topic><topic>RABBITS</topic><topic>REPRINTS</topic><topic>THROMBIN</topic><topic>VENOMS</topic><toplevel>online_resources</toplevel><creatorcontrib>Krishnamurti, Chitra</creatorcontrib><creatorcontrib>Bolan, Charles</creatorcontrib><creatorcontrib>Colleton, Curtis A</creatorcontrib><creatorcontrib>Reilly, Thomas M</creatorcontrib><creatorcontrib>Alving, Barbara M</creatorcontrib><creatorcontrib>WALTER REED ARMY INST OF RESEARCH WASHINGTON DC</creatorcontrib><collection>DTIC Technical Reports</collection><collection>DTIC STINET</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Krishnamurti, Chitra</au><au>Bolan, Charles</au><au>Colleton, Curtis A</au><au>Reilly, Thomas M</au><au>Alving, Barbara M</au><aucorp>WALTER REED ARMY INST OF RESEARCH WASHINGTON DC</aucorp><format>book</format><genre>unknown</genre><ristype>RPRT</ristype><btitle>Role of Plasminogen Activator Inhibitor-1 in Promoting Fibrin Deposition in Rabbits Infused with Ancrod or Thrombin</btitle><date>1993-12-15</date><risdate>1993</risdate><abstract>The role of defective, fibrinolysis caused by elevated activity of plasminogen activator inhibitor-1 (PAI-1) in promoting fibrin deposition in vivo has not been well established. The present study compared the efficacy of thrombin or ancrod, a venom-derived enzyme that clots fibrinogen, to induce fibrin formation in rabbits with elevated PAI-1 levels. One set of male New Zealand rabbits received intravenous endotoxin to increase endogenous PAI-1 activity followed by a 1 -hour infusion of ancrod or thrombin; another set of normal rabbits received intravenous human recombinant PAI-1 (rPAI-1) during an infusion of ancrod or thrombin. Thirty minutes after the end of the infusion, renal fibrin deposition was assessed by histopathology. Animals receiving endotoxin, rPAI-1 , ancrod, or thrombin alone did not develop renal thrombi.
Pub. in Blood, v82, n12, p3631-3636, 15 Dec 1993.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_dtic_stinet_ADA275301 |
source | DTIC Technical Reports |
subjects | ANIMALS Biochemistry BLOOD COAGULATION DEPOSITION ENDOTOXINS ENZYME PRECURSORS ENZYMES FIBRIN FIBRINOGEN FIBRINOLYSIS HISTOPATHOLOGY HUMANS IN VIVO ANALYSIS INFUSIONS INHIBITORS MALES NEW ZEALAND PHYSIOLOGY RABBITS REPRINTS THROMBIN VENOMS |
title | Role of Plasminogen Activator Inhibitor-1 in Promoting Fibrin Deposition in Rabbits Infused with Ancrod or Thrombin |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-24T21%3A23%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-dtic_1RU&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.btitle=Role%20of%20Plasminogen%20Activator%20Inhibitor-1%20in%20Promoting%20Fibrin%20Deposition%20in%20Rabbits%20Infused%20with%20Ancrod%20or%20Thrombin&rft.au=Krishnamurti,%20Chitra&rft.aucorp=WALTER%20REED%20ARMY%20INST%20OF%20RESEARCH%20WASHINGTON%20DC&rft.date=1993-12-15&rft_id=info:doi/&rft_dat=%3Cdtic_1RU%3EADA275301%3C/dtic_1RU%3E%3Cgrp_id%3Ecdi_FETCH-dtic_stinet_ADA2753013%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |